CMND

Clearmind Medicine reveals further positive pre-clinical results for cocaine addiction treatment

Clearmind Medicine (CSE: CMND) has achieved further positive pre-clinical results in its novel psychedelic molecule MEAI treatment for cocaine addiction. MEAI is the company’s flagship therapeutic and has low toxicity, along with a strong safety profile and no side effects. Through a recent study, results suggested MEAI can play a role in abolishing cocaine-induced conditioned […]